Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230515 · ClinicalTrials.gov registry record
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
A clinical trial of Cancer Pain, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT01230515: Completed study of Cancer Pain, sponsored by Vanderbilt-Ingram Cancer Center.
NCT01230515 is a study of Cancer Pain that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 65 participants, below the 158-participant average among 15 other Cancer Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230515, a study of Cancer Pain, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.
Conditions Studied
Interventions
- OTHER Individual patient interview, focus group and structured survey
- OTHER interview, focus group and structured survey
Study Locations (1)
Tennessee
- Vanderbilt-Ingam Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-03 |
What the finished NCT01230515 record still lists
NCT01230515 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 158-participant average among 15 other Cancer Pain trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Cancer Pain appearing as the primary indexed condition, and to 2 interventions - of which Individual patient interview, focus group and structured survey is the first listed.
NCT01230515 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01230515 about?
NCT01230515 is a clinical study titled "Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol". The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.
What is the current status of trial NCT01230515?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2006-01. Estimated completion is 2008-03.
What conditions does trial NCT01230515 study?
This clinical trial studies the following conditions: Cancer Pain.
What interventions are being tested in trial NCT01230515?
The interventions under investigation include: Individual patient interview, focus group and structured survey (OTHER), interview, focus group and structured survey (OTHER).
Who is sponsoring clinical trial NCT01230515?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01230515 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01230515's enrollment target sits among peer trials
65 10th of 15 higher than 6 of 15 other Cancer Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
RECRUITING · NA
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Cancer Pain Management Using a Web-based Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia